Angel · USA
Zygote invests first or very early in technology, biotech, and agriculture companies that can 'change the game' and improve the world in a meaningful way. As a principal-only investor with no limited partners, Zygote is less risk-averse than traditional VCs and can choose to partner where it can provide real value.
Business models
deeptech_ip, hardware, biotech_therapeutics, platform
Customer segments
Enterprise, Healthcare providers, Energy sector, Agriculture
Geography
US
+ 2 more deals. Score your deck to see the full investment history.
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Zygote Ventures writes individual checks. Angels carry outsized signal early — the right names on a SAFE turn warm intros to institutional rounds faster than any other lever — and they decide in hours, not weeks. Claude Fundraiser tracks Zygote Ventures alongside 45,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
01 Ventures
DeepTech, AI, Industry 4.0 / Robotics
Seed VC
13 Ventures
DeepTech, Healthtech, Biotech
Seed VC
1517 Fund
DeepTech, AI, Industry 4.0 / Robotics
Seed VC
1855 Capital Partners
DeepTech, AI, Materials
Seed VC
1955 Capital
Climate Tech, Energy, Food and agritech
Seed VC
1confirmation
DeepTech, AI, Crypto
Drop your pitch. Claude scores it on the 8 dimensions VCs read for and ranks the 45,000+ active investors in the database by fit. Zygote Ventures is one of them — and we'll tell you exactly where they sit in your top 100.